Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells

Cell Reports(2023)10.1016/j.celrep.2023.112040Source: DataRank Database

JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells is a research paper published in Cell Reports (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

geo dbgap hpa

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: goldTopics (40)IDs (PubMed, PMC)Annotations (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Alice Wang ORCID,Ciro Ramírez-Suástegui ORCID,Adrian von Witzleben ORCID,Yingcong Li ORCID,Serena Chee ORCID

Live enrichment

PubMed:36701231 PMC:PMC10366340

National Institutes of Health

Grant: S10OD016262

NIH HHS

Grant: S10 OD025052

NCRR NIH HHS

Grant: S10 RR027366

National Institutes of Health

Grant: 1S10RR027366-01A1

FACSAria II Cell Sorter

National Institutes of Health

Grant: 1S10OD025052-01

NovaSeq5000 High Throughput Sequencer

National Institutes of Health

Grant: 1S10OD016262-01

Illumina HiSeq 2500 Sequencing System

Pfizer

William K Bowes Jr Foundation

Whitaker Foundation

goldLicense: cc-by-nc-nd

publisherhttp://www.cell.com/article/S2211124723000517/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124723000517?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124723000517?httpAccept=text/plain

repositoryhttps://eprints.soton.ac.uk/475927/1/1_s2.0_S2211124723000517_main.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10366340/pdf/nihms-1878876.pdf

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

CD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingAnimalsHumansMiceNeoplasmsCell Adhesion MoleculesImmunotherapyJunctional Adhesion Molecules

Keywords

tumor immunologyAgonistic antibodyCancer Immunotherapyco-stimulatory moleculeJamlCp: ImmunologyCp: CancerTrm CellsMedical SciencesJunctional Adhesion MoleculesBioinformaticsQH301-705.5610CD8-Positive T-LymphocytesBiomedical InformaticsMiceLymphocytes, Tumor-InfiltratingOncologyNeoplasmsMedical SpecialtiesMedicine and Health SciencesHumansAnimalsLymphocytesTumor-InfiltratingImmunotherapyBiology (General)Cell Adhesion Molecules